ServiceUpdated on 20 August 2025
PHOENIX SEP: Your Single Entry Point for Nanopharmaceutical Development
About
PHOENIX supports its customers to overcome the "innovation valley of death", enabling transfer of nanopharmaceuticals from lab bench to clinical trials.
PHOENIX provides a Single Entry Point (SEP) for a network of facilities, technologies, services and expertise for all the RDI and technology transfer aspects from characterization, testing, verification up to scale-up, GMP manufacturing and regulatory guidance in a timely and cost-friendly manner.
Contact us now to see how PHOENIX can help your nanopharmaceutical innovation catch fire!
Type
- Development
- Consulting
- Manufacturing
- Others
Applies to
- Microtechnology
- Biotech and Lifescience
- Medtech
Organisation
Similar opportunities
Expertise
Single Entry Point (SEP) for Nano-pharmaceutical Innovative Products
- Biotech, Pharma and Cosmetics
Service
- Development
- Manufacturing
- Biotech and Lifescience